5DS — MegaChem Cashflow Statement
0.000.00%
- SG$56.65m
- SG$82.13m
- SG$124.41m
Annual cashflow statement for MegaChem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.99 | 6.07 | -5.34 | 8.69 | 4.27 |
| Depreciation | |||||
| Non-Cash Items | 0.277 | 1.75 | 10.2 | 1.59 | 0.215 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17.3 | -12.1 | 9.53 | -0.53 | -0.154 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.86 | -2.97 | 15.8 | 11 | 5.65 |
| Capital Expenditures | -3.42 | -1.66 | -1.19 | -2.74 | -14.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.633 | 1.65 | -0.72 | 0.321 | 0.549 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.79 | -0.012 | -1.91 | -2.41 | -13.7 |
| Financing Cash Flow Items | -0.636 | -1.13 | -1.97 | -2.03 | -1.47 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.81 | 3.15 | -11.6 | -6.51 | 6.82 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.81 | -0.158 | 2.07 | 2.27 | -1.28 |